Explore more publications!
Africa News Currents
Got News to Share?

Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 23, 2026

NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit
Mar. 23, 2026

NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit

Indeterminate GlobeNewswire
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Mar. 23, 2026

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

Indeterminate GlobeNewswire
Terra Balcanica Announces Private Placement Financing
Mar. 23, 2026

Terra Balcanica Announces Private Placement Financing

Indeterminate GlobeNewswire
Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting
Mar. 23, 2026

Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting

Indeterminate GlobeNewswire
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Mar. 23, 2026

ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax

Indeterminate GlobeNewswire
Tempest Therapeutics Announces Up To $6 Million Private Placement
Mar. 23, 2026

Tempest Therapeutics Announces Up To $6 Million Private Placement

Indeterminate GlobeNewswire
Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Mar. 23, 2026

Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
Mar. 23, 2026

BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions

Indeterminate GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar. 23, 2026

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. SUBMITS APPLICATION TO NOAA UNDER DEEP SEABED HARD MINERAL RESOURCES ACT
Mar. 23, 2026

DEEP SEA MINERALS CORP. SUBMITS APPLICATION TO NOAA UNDER DEEP SEABED HARD MINERAL RESOURCES ACT

Indeterminate GlobeNewswire
OR Royalties Appoints Mr. Patrick Godin to Its Board of Directors
Mar. 23, 2026

OR Royalties Appoints Mr. Patrick Godin to Its Board of Directors

Indeterminate GlobeNewswire
Redevances OR nomme M. Patrick Godin au sein de son conseil d'administration
Mar. 23, 2026

Redevances OR nomme M. Patrick Godin au sein de son conseil d'administration

Indeterminate GlobeNewswire
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
Mar. 23, 2026

Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company

Indeterminate GlobeNewswire
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
Mar. 23, 2026

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

Indeterminate GlobeNewswire
Trident Resources Announces Strategic Appointment of David Chan, P.Geo as Technical Advisor
Mar. 23, 2026

Trident Resources Announces Strategic Appointment of David Chan, P.Geo as Technical Advisor

Indeterminate GlobeNewswire
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 23, 2026

Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Brunswick Exploration Closes Final Tranche of Non-Brokered Private Placement for Total Gross Proceeds of $5,445,000
Mar. 23, 2026

Brunswick Exploration Closes Final Tranche of Non-Brokered Private Placement for Total Gross Proceeds of $5,445,000

Indeterminate GlobeNewswire
Lithium Argentina Reports Fourth Quarter and Full Year 2025 Results
Mar. 23, 2026

Lithium Argentina Reports Fourth Quarter and Full Year 2025 Results

Indeterminate GlobeNewswire
MEXC and Ondo Finance Expand Tokenized Stock Partnership with 19 New Spot Pairs and Zero-Fee Trading
Mar. 23, 2026

MEXC and Ondo Finance Expand Tokenized Stock Partnership with 19 New Spot Pairs and Zero-Fee Trading

Indeterminate GlobeNewswire
Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
Mar. 23, 2026

Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions